Protalix BioTherapeutics (PLX) Capital Expenditures Growth (1y) (2011 - 2026)
Protalix BioTherapeutics (PLX) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Protalix BioTherapeutics |
176.47 Mn |
165.67 Mn |
29.62 Mn |
-33.02% |
| Date | Value |
|---|
| Mar 31, 2026 |
-33.02% |
| Dec 31, 2025 |
-43.62% |
| Sep 30, 2025 |
-32.34% |
| Jun 30, 2025 |
164.99% |
| Mar 31, 2025 |
-28.60% |
| Dec 31, 2024 |
-267.04% |
| Sep 30, 2024 |
469.85% |
| Jun 30, 2024 |
-333.82% |
| Mar 31, 2024 |
141.13% |
| Dec 31, 2023 |
682.26% |
| Sep 30, 2023 |
-260.48% |
| Jun 30, 2023 |
237.84% |
| Mar 31, 2023 |
8.30% |
| Dec 31, 2022 |
-113.84% |
| Sep 30, 2022 |
-63.95% |
| Jun 30, 2022 |
-152.67% |
| Mar 31, 2022 |
-40.67% |
| Dec 31, 2021 |
811.11% |
| Sep 30, 2021 |
237.25% |
| Jun 30, 2021 |
32.55% |
